Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients

Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 Monreal, 2004, The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients: findings from the RIETE registry, J Thromb Haemost, 2, 1892, 10.1111/j.1538-7836.2004.01012.x Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study, Arch Intern Med, 162, 1245, 10.1001/archinte.162.11.1245 Baglin, 1997, Fatal pulmonary embolism in hospitalised medical patients, J Clin Pathol, 50, 609, 10.1136/jcp.50.7.609 Cohen, 1996, The changing pattern of venous thromboembolic disease, Haemostasis, 26, 65 Sandler, 1989, Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?, J R Soc Med, 82, 203, 10.1177/014107688908200407 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24 Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Nicolaides, 2006, Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence), Int Angiol, 25, 101 Ageno, 2002, Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns, Haematologica, 87, 746 Ahmad, 2002, Deep venous thrombosis prophylaxis: are guidelines being followed?, ANZ J Surg, 72, 331, 10.1046/j.1445-2197.2002.02402.x Bergmann, 2002, Thromboprophylaxis in medical patients: focus on France, Semin Thromb Hemost, 28, 51, 10.1055/s-2002-34077 Goldhaber, 2004, A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis, Am J Cardiol, 93, 259, 10.1016/j.amjcard.2003.09.057 Chopard, 2005, Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement, J Intern Med, 257, 352, 10.1111/j.1365-2796.2005.01455.x Kahn, 2007, Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada, Thromb Res, 119, 145, 10.1016/j.thromres.2006.01.011 Stinnett, 2005, Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates, Am J Hematol, 78, 167, 10.1002/ajh.20281 Geerts, 2001, Prevention of venous thromboembolism, Chest, 119, 132S, 10.1378/chest.119.1_suppl.132S Mismetti, 2000, Prevention of venous thromboembolism in internal medicine with unfractionated heparin or low-molecular-weight heparins: a meta-analysis of randomised clinical trials, Thromb Haemost, 83, 14, 10.1055/s-0037-1613749 Alikhan, 2003, A safety analysis of thromboprophylaxis in acute medical illness, Thromb Haemost, 89, 590, 10.1055/s-0037-1613391 Warkentin, 1995, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin, N Engl J Med, 332, 1330, 10.1056/NEJM199505183322003 Warkentin, 2004, Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 311S, 10.1378/chest.126.3_suppl.311S Arnold, 2001, Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines, Chest, 120, 1964, 10.1378/chest.120.6.1964 Learhinan, 2003, Venous thromboembolism prophylaxis in a South Australian teaching hospital, Ann Pharmacother, 37, 1398, 10.1345/aph.1D100 Burns, 2001, Venous thromboembolism prophylaxis used by consultant general surgeons in Scotland, J R Coll Surg Edinb, 46, 329 Caiafa, 2002, Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian registry, Semin Thromb Haemost, 28, 47, 10.1055/s-2002-34076 Schünemann, 2004, Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 688S, 10.1378/chest.126.3_suppl.688S Kucher, 2005, Electronic alerts to prevent venous thromboembolism among hospitalized patients, N Engl J Med, 352, 969, 10.1056/NEJMoa041533 Kakkar, 2004, Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines, J Thromb Haemost, 2, 221, 10.1111/j.1538-7933.2004.00588.x Vallano, 2004, Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study, Thromb J, 2, 3, 10.1186/1477-9560-2-3